American Association for Cancer Research
mcr-22-0415_supplementary_figure_2_suppsf2.docx (128.89 kB)

Supplementary Figure 2 from XIAP and PHB1 Regulate Anoikis through Competitive Binding to TRAF6

Download (128.89 kB)
journal contribution
posted on 2023-04-03, 20:03 authored by Bo Yang, Chao Lou, Shengkai Chen, Zhiyuan Zhang, Qin Xu

S2. Effects of CAPE on NF-kappaB signaling activation.


National Natural Science Foundation of China (NSFC)

Innovative Research Team of High-level Local Universities in Shanghai



Anoikis resistance is a prerequisite for circulating tumor cells to survive. However, the mechanism underlying anoikis resistance is poorly understood. In the current study, the effect of TNF receptor–associated factor 6 (TRAF6)-induced NF-kB activation on anoikis susceptibility in tumor cells was evaluated. Differential TRAF6-binding proteins in anoikis-sensitive versus anoikis-resistant tumor cells were screened by LC/MS-MS analysis. The effects of TRAF6-binding proteins on the stability of TRAF6, the activation of NF-kB signaling and anoikis susceptibility in tumor cells were detected. We found that the loss of TRAF6 expression is an important molecular event linked to anoikis. X-linked inhibitor of apoptosis protein (XIAP), an E3 ligase, can bind, ubiquitinate, and degrade TRAF6 and may lead to inactivation of NF-κB signaling and anoikis sensitivity. High expression of prohibitin 1 (PHB1) competes with XIAP for binding to TRAF6 and confers anoikis resistance to tumor cells. PHB1 and TRAF6 knockdown eliminated tumor cells from the circulation in vivo. Significant correlations between elevated PHB1 and TRAF6 expression and distant metastasis were observed in patients with oral cancer. Collectively, we elucidated a novel mechanism governing anoikis. Our data also indicated that TRAF6 and PHB1 are potential therapeutic targets for tumor cells disseminating in the circulation. Our data implicate that PHB1 competes with XIAP for binding to TRAF6 and confers anoikis resistance to tumor cells.

Usage metrics

    Molecular Cancer Research





    Ref. manager